LPM-4870108 | Interleukin Related interleukin-related.com

Product Name :
LPM-4870108

Search keywords :
LPM4870108

drugId :
null

Target Vo:
Neurotrophic tyrosine kinase receptor

Target Vo Short Name :
NTRK

Moa_Name:
Neurotrophic tyrosine kinase receptor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Luye Pharma Group Ltd

Active Company_Name :
Nanjing Kanghai Phospholipid Biotechnology Co Ltd

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HER2 Rabbit mAb site
Tegoprubart Biological Activity
SRT Tag Antibody (YA884): SRT Tag Antibody (YA884) is an unconjugated, mouse-derived, anti-SRT Tag (YA884) monoclonal antibody. SRT Tag Antibody (YA884) can be used for: WB expriments in species-independent background without labeling.

Author: Interleukin Related

Related Posts